基于第一代CRISPR/Cas系统的基因编辑技术在生物医学中的应用
参考文献:
1.Wang,Haifeng; La Russa, Marie; Qi, Lei S. CRISPR/Cas9 in genome editingand beyond. Annu Rev Biochem 2016, 85, 227-264.
2.Adli,Mazhar. The CRISPR tool kit for genome editing and beyond. Naturecommunications 2018, 9, 1-13.
3.Ran,F Ann; Hsu, Patrick D; Lin, Chie-Yu; Gootenberg, Jonathan S;Konermann, Silvana; Trevino, Alexandro E; Scott, David A; Inoue,Azusa; Matoba, Shogo; Zhang, Yi. Double nicking by RNA-guided CRISPRCas9 for enhanced genome editing specificity. Cell 2013,154, 1380-1389.
4. Sanjana,Neville E; Shalem, Ophir; Zhang, Feng. Improved vectors andgenome-wide libraries for CRISPR screening. Nature methods 2014,11, 783-784.
5. Sanson,Kendall R; Hanna, Ruth E; Hegde, Mudra; Donovan, Katherine F; Strand,Christine; Sullender, Meagan E; Vaimberg, Emma W; Goodale, Amy; Root,David E; Piccioni, Federica. Optimized libraries for CRISPR-Cas9genetic screens with multiple modalities. Nature communications2018, 9, 1-15.
6. Pflueger,Christian; Tan, Dennis; Swain, Tessa; Nguyen, Trung; Pflueger,Jahnvi; Nefzger, Christian; Polo, Jose M; Ford, Ethan; Lister, Ryan.A modular dCas9-SunTag DNMT3A epigenome editing system overcomespervasive off-target activity of direct fusion dCas9-DNMT3Aconstructs. Genome research 2018, 28, 1193-1206.
7. Morita,Sumiyo; Noguchi, Hirofumi; Horii, Takuro; Nakabayashi, Kazuhiko;Kimura, Mika; Okamura, Kohji; Sakai, Atsuhiko; Nakashima, Hideyuki;Hata, Kenichiro; Nakashima, Kinichi. Targeted DNA demethylation invivo using dCas9–peptide repeat and scFv–TET1 catalytic domainfusions. Nature biotechnology 2016, 34,1060-1065.
8. Lopes,Rui; Korkmaz, Gozde; Agami, Reuven. Applying CRISPR–Cas9 tools toidentify and characterize transcriptional enhancers. NatureReviews Molecular Cell Biology 2016, 17, 597-604.
9. Kearns,Nicola A; Pham, Hannah; Tabak, Barbara; Genga, Ryan M; Silverstein,Noah J; Garber, Manuel; Maehr, René. Functional annotation of nativeenhancers with a Cas9–histone demethylase fusion. Nature methods2015, 12, 401-403.
10. Brocken,Daan JW; Tark-Dame, Mariliis; Dame, Remus T. dCas9: a versatile toolfor epigenome editing. Current issues in molecular biology 2018,26, 15-32.
11. Hong,Yu; Lu, Guangqing; Duan, Jinzhi; Liu, Wenjing; Zhang, Yu. Comparisonand optimization of CRISPR/dCas9/gRNA genome-labeling systems forlive cell imaging. Genome biology 2018, 19,1-10.
12. Chen,Baohui; Zou, Wei; Xu, Haiyue; Liang, Ying; Huang, Bo. Efficientlabeling and imaging of protein-coding genes in living cells usingCRISPR-Tag. Nature communications 2018, 9, 1-9.
13. Chen,Baohui; Guan, Juan; Huang, Bo. Imaging specific genomic DNA in livingcells. 2016.
14. Wu,Xiaotian; Mao, Shiqi; Ying, Yachen; Krueger, Christopher J; Chen,Antony K. Progress and challenges for live-cell imaging of genomicloci using CRISPR-based platforms. Genomics, proteomics &bioinformatics 2019, 17, 119-128.
15. Dolgalev,Georgii; Poverennaya, Ekaterina. Applications of CRISPR-CasTechnologies to Proteomics. Genes 2021, 12,1790.
16. Yi,Wenkai; Li, Jingyu; Zhu, Xiaoxuan; Wang, Xi; Fan, Ligang; Sun, Wenju;Liao, Linbu; Zhang, Jilin; Li, Xiaoyu; Ye, Jing. CRISPR-assisteddetection of RNA–protein interactions in living cells. Naturemethods 2020, 17, 685-688.
17. Halperin,Shakked O; Tou, Connor J; Wong, Eric B; Modavi, Cyrus; Schaffer,David V; Dueber, John E. CRISPR-guided DNA polymerases enablediversification of all nucleotides in a tunable window. Nature2018, 560, 248-252.
18. Strecker,Jonathan; Ladha, Alim; Gardner, Zachary; Schmid-Burgk, Jonathan L;Makarova, Kira S; Koonin, Eugene V; Zhang, Feng. RNA-guided DNAinsertion with CRISPR-associated transposases. Science 2019,365, 48-53.
19. Klompe,Sanne E; Vo, Phuc LH; Halpin-Healy, Tyler S; Sternberg, Samuel H.Transposon-encoded CRISPR–Cas systems direct RNA-guided DNAintegration. Nature 2019, 571, 219-225.
20. Morisaka,Hiroyuki; Yoshimi, Kazuto; Okuzaki, Yuya; Gee, Peter; Kunihiro,Yayoi; Sonpho, Ekasit; Xu, Huaigeng; Sasakawa, Noriko; Naito, Yuki;Nakada, Shinichiro. CRISPR-Cas3 induces broad and unidirectionalgenome editing in human cells. Nature communications 2019,10, 1-13.
21. Dolan,Adam E; Hou, Zhonggang; Xiao, Yibei; Gramelspacher, Max J; Heo,Jaewon; Howden, Sara E; Freddolino, Peter L; Ke, Ailong; Zhang, Yan.Introducing a spectrum of long-range genomic deletions in humanembryonic stem cells using type I CRISPR-Cas. Molecular cell 2019,74, 936-950. e935.
22. Perli,Samuel D; Cui, Cheryl H; Lu, Timothy K. Continuous genetic recordingwith self-targeting CRISPR-Cas in human cells. Science 2016,353, aag0511.
23. Mustafa,Mujahed I; Makhawi, Abdelrafie M. SHERLOCK and DETECTR: CRISPR-Cassystems as potential rapid diagnostic tools for emerging infectiousdiseases. Journal of Clinical Microbiology 2021, 59,e00745-00720.
24. Petri,Karl; Pattanayak, Vikram. SHERLOCK and DETECTR open a new frontier inmolecular diagnostics. The CRISPR journal 2018, 1,209-211.
25. Gillmore,Julian D; Gane, Ed; Taubel, Jorg; Kao, Justin; Fontana, Marianna;Maitland, Michael L; Seitzer, Jessica; O’Connell, Daniel; Walsh,Kathryn R; Wood, Kristy. CRISPR-Cas9 in vivo gene editing fortransthyretin amyloidosis. New England Journal of Medicine 2021,385, 493-502.
—END—
往期文章推荐:
国内核酸类(mRNA)疫苗企业再盘点!(截止2022年6月)
两款CAR-T细胞基因疗法纳入“沪惠保”,已开启线上预约投保
目前国内获批或申请已被受理的AAV基因疗法临床试验已达20项